Metipranolol patient counseling information
From Wikidoc - Reading time: 1 min
| Metipranolol |
|---|
| METIPRANOLOL® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| How Supplied/Storage and Handling |
| Patient Counseling Information |
| Labels and Packages |
| Clinical Trials on Metipranolol |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Patient Counseling Information[edit | edit source]
Information for Patients[edit | edit source]
Patients should be instructed to avoid allowing the tip of the dispensing containers to contact the eye or surrounding structures. Patients should be advised that metipranolol contains benzalkonium chloride which may be absorbed by soft contact lenses. Contact lenses should be removed prior to administration of the solution. Lenses may be reinserted 15 minutes following metipranolol administration.[1]
References[edit | edit source]
Adapted from the FDA Package Insert.
Licensed under CC BY-SA 3.0 | Source: https://www.wikidoc.org/index.php/Metipranolol_patient_counseling_information1 | Status: cached on November 18 2023 08:04:22↧ Download this article as ZWI file
EncycloReader
is supported by the 
KSF